Form 4: Cryoport CFO Robert Stefanovich Sells 169K Shares
Statement of Changes in Beneficial Ownership
Cryoport, Inc. Chief Financial Officer Robert Stefanovich sold 169,427 shares of common stock on June 4, 2026.
Summary
- CFO Robert Stefanovich executed a sale of 169,427 shares of Cryoport, Inc. common stock.
- The shares were sold at a weighted average price of $16.2724 per share.
- The transaction occurred on June 4, 2026.
- Following the sale, the reporting person retains beneficial ownership of 109,850 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event; while insider selling can be perceived as a negative signal, it is a routine disclosure of a financial transaction and does not inherently indicate operational distress.
Positives
- The transaction was executed at a weighted average price of $16.2724, reflecting current market valuation.
Negatives
- Significant insider selling by a high-level executive (CFO) can sometimes be perceived negatively by the market as a signal of reduced confidence or personal liquidity needs.
Risks
- Market perception of insider selling may lead to increased volatility in the company's share price.
Future Outlook
No forward-looking guidance or strategic outlook was provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that insider selling by C-suite executives is a common occurrence for liquidity or tax planning purposes and does not necessarily reflect a change in the company's fundamental business outlook.
Comparison to Industry Standards
- Insider transactions are standard regulatory disclosures for publicly traded companies in the life sciences logistics sector.
- The scale of the sale relative to the remaining holdings is consistent with typical executive portfolio rebalancing.
Stakeholder Impact
- Shareholders should monitor for potential short-term price volatility following the disclosure of significant insider selling.
Key Dates
| Date | Description |
|---|---|
| 06/04/2026 | Date of the reported stock sale transaction. |
| 06/08/2026 | Date the Form 4 was signed and filed. |
Keywords
Cryoport, CYRX, Insider Trading, Form 4, CFO, Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.